Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Hypertension (PH)”

146 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 146 results

Testing effectiveness (Phase 2)Study completedNCT03624010
What this trial is testing

Open-Label Rollover Study of Levosimendan in PH-HFpEF Patients

Who this might be right for
Hypertension Pulmonary Secondary Heart FailureRight Sided Heart Failure With Normal Ejection FractionHeart Failure With Normal Ejection Fraction
Tenax Therapeutics, Inc. 20
Not applicableWithdrawnNCT05693779
What this trial is testing

Exercise Therapy After Pulmonary Thromboendarterectomy or Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension

Who this might be right for
Chronic Thromboembolic Pulmonary Hypertension
University of Michigan
Testing effectiveness (Phase 2)Study completedNCT03814317
What this trial is testing

Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension

Who this might be right for
SarcoidosisPrecapillary Pulmonary HypertensionInterstitial Lung Disease
University of Florida 5
Not applicableLooking for participantsNCT07120789
What this trial is testing

Validation of a Patient Knowledge Questionnaire for Pulmonary Hypertension

Who this might be right for
Pulmonary Arterial Hypertension (PAH)Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)Pulmonary Hypertension
University of Sao Paulo General Hospital 215
Testing effectiveness (Phase 2)Study completedNCT02036970
What this trial is testing

Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT

Who this might be right for
Pulmonary Arterial HypertensionPulmonary HypertensionInterstitial Lung Disease+9 more
Biogen 166
Not applicableNot Yet RecruitingNCT05464238
What this trial is testing

Training in HFpEF-PH

Who this might be right for
Pulmonary Hypertension Due to Left Heart DiseaseHeart Failure With Preserved Ejection Fraction
Heidelberg University 90
Not applicableNot Yet RecruitingNCT07263958
What this trial is testing

Hemodynamic Effects of Inhaled Iloprost in PH-COPD (HOLLYWOOD)

Who this might be right for
Pulmnary HypertensionCOPDPulmonary Hypertension Secondary to Lung Disease and/or Hypoxia
University of Sao Paulo General Hospital 15
Testing effectiveness (Phase 2)Ended earlyNCT02138825
What this trial is testing

Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)

Who this might be right for
Idiopathic Interstitial Pneumonias / Hypertension,Pulmonary
Bayer 147
Not applicableStudy completedNCT02565030
What this trial is testing

Chronic Thrombo-embolic Pulmonary Hypertension: Classification and Long Term Outcome

Who this might be right for
Chronic Thromboembolic Pulmonary HypertensionIdiopathic Pulmonary Arterial Hypertension
Sheffield Teaching Hospitals NHS Foundation Trust 1,200
Not applicableLooking for participantsNCT05610631
What this trial is testing

Pulmonary Hypertension Registry Switzerland

Who this might be right for
Pulmonary Hypertension
University of Zurich 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT07333183
What this trial is testing

Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

Who this might be right for
Pulmonary HypertensionInterstitial Lung Disease (ILD)Lung Diseases+3 more
Pulmovant, Inc. 20
Testing effectiveness (Phase 2)Looking for participantsNCT06814145
What this trial is testing

Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)

Who this might be right for
Hypertension, Pulmonary
Merck Sharp & Dohme LLC 130
Not applicableStudy completedNCT03667794
What this trial is testing

Evaluation of Novel Lung Function Parameters in Patients With Pulmonary Hypertension (PH)

Who this might be right for
Pulmonary Hypertension
Universitätsmedizin Mannheim 75
Testing effectiveness (Phase 2)Study completedNCT03541603
What this trial is testing

Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF

Who this might be right for
Hypertension Pulmonary SecondaryHeart Failure, Right SidedHeart Failure With Normal Ejection Fraction
Tenax Therapeutics, Inc. 44
Large-scale testing (Phase 3)Looking for participantsNCT05983250
What this trial is testing

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

Who this might be right for
Pulmonary Hypertension
Tenax Therapeutics, Inc. 230
Not applicableLooking for participantsNCT06090838
What this trial is testing

BPA in CTEPD Without PH

Who this might be right for
Chronic Thromboembolic Disease
Amsterdam UMC, location VUmc 60
Not applicableUnknownNCT02368171
What this trial is testing

Role of Heme-oxygenase (HO) and Nitric Oxide (NO) Pathway in Patients With Obstructive Sleep Apnea (OSA) and Pulmonary Hypertension (PH)

Who this might be right for
Obstructive Sleep ApneaPulmonary Hypertension
Southern California Institute for Research and Education 60
Not applicableStudy completedNCT02647060
What this trial is testing

The Exercise Capacity and Quality of Life in the Patients With IPAH and Secondary PH

Who this might be right for
Hypertension, Pulmonary
National Taiwan University Hospital 26
Not applicableLooking for participantsNCT06850792
What this trial is testing

ImprOving Adherence to Pulmonary artErial hyperteNsion Treatment With teLemedicIne and patieNt guidaNce

Who this might be right for
Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)Pulmonary Arterial Hypertension (PAH)Pulmonary Arterial Hypertension
University of Sao Paulo General Hospital 61
Testing effectiveness (Phase 2)Ended earlyNCT03924154
What this trial is testing

RVT-1201 in Patients With Pulmonary Arterial Hypertension (ELEVATE 1)

Who this might be right for
Pulmonary Arterial Hypertension
Altavant Sciences GmbH 3
Load More Results